Zogenix is committed to developing and commercialising therapies with the potential to transform the lives of patients and their families living with rare diseases.
Innovation in Rare Disease
Zogenix is a growing U.S.-headquartered pharmaceutical company passionate about taking on the complex challenges of developing therapeutic solutions with the potential to transform the lives of rare disease patients and their families.
To learn more about our current development projects, click here.
At Zogenix, we strive to make a difference in the lives of patients, their families, and our employees by operating ethically with the following values:
Zogenix global headquarters is in the United States. The company has additional offices in Europe and Japan.
To learn more about our locations and how to contact us, click here.
We continually review opportunities identified by our business development team and strategic investment partners. To discuss potential business development opportunities, please contact: firstname.lastname@example.org